Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene

Phosphoglucomutase 3 (PGM3) is an enzyme converting N-acetyl-glucosamine-6-phosphate to N-acetyl-glucosamine-1-phosphate, a precursor important for glycosylation. Mutations in the PGM3 gene have recently been identified as the cause of novel primary immunodeficiency with a hyper-IgE like syndrome. H...

Description complète

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 161(2015), 2 vom: 25. Dez., Seite 366-72
Auteur principal: Lundin, Karin E (Auteur)
Autres auteurs: Hamasy, Abdulrahman, Backe, Paul Hoff, Moens, Lotte N, Falk-Sörqvist, Elin, Elgstøen, Katja B, Mørkrid, Lars, Bjørås, Magnar, Granert, Carl, Norlin, Anna-Carin, Nilsson, Mats, Christensson, Birger, Stenmark, Stephan, Smith, C I Edvard
Format: Article en ligne
Langue:English
Publié: 2015
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Case Reports Journal Article Research Support, Non-U.S. Gov't CDG Congenital defects of glycosylation N-acetylglucosamine-phosphate mutase Primary immunodeficiency hyper-IgE syndrome PGM3 protein, human EC 5.4.2.2 Phosphoglucomutase